Coverage of pharmacogenetic tests by private health insurance companies.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

To assess the coverage of clinically relevant pharmacogenetic tests by the top 41 private insurance companies in the United States.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Am Pharm Assoc (2003)

Title: Journal of the American Pharmacists Association : JAPhA

Publisher: Elsevier BV

ISSN (Electronic): 1544-3450

ISSN (Print): 1086-5802

Publication date (Electronic): December 18 2019

Volume: 60

Issue: 2

Article

Publisher Item ID: S1544-3191(19)30452-2

DOI: 10.1016/j.japh.2019.10.003

PubMed ID: 31843376

SO-VID: e4c62140-71f2-4087-b5e3-34c6ca49bba9

Data availability:

Comments

Comment on this article

Cited by 5

See all cited by

Coverage of pharmacogenetic tests by private health insurance companies.

Read this article at

SciELO Public Health

Journal

Article

Comment on this article